TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
115.18
+0.21 (0.18%)
At close: Aug 26, 2025, 4:00 PM
115.00
-0.18 (-0.16%)
After-hours: Aug 26, 2025, 4:17 PM EDT

TransMedics Group Stock Forecast

Stock Price Forecast

The 8 analysts that cover TransMedics Group stock have a consensus rating of "Buy" and an average price target of $123, which forecasts a 6.79% increase in the stock price over the next year. The lowest target is $75 and the highest is $150.

Price Target: $123 (+6.79%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$75$123$123$150
Change-34.88%+6.79%+6.79%+30.23%

Analyst Ratings

The average analyst rating for TransMedics Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy333333
Buy444443
Hold333333
Sell000000
Strong Sell000000
Total10101010109

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Needham
Needham
Hold
Reiterates
n/a
HoldReiteratesn/an/aAug 25, 2025
Morgan Stanley
Morgan Stanley
Hold
Maintains
$115$123
HoldMaintains$115$123+6.79%Aug 1, 2025
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$129$142
Strong BuyMaintains$129$142+23.29%Jul 15, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$130$150
BuyMaintains$130$150+30.23%Jun 17, 2025
Needham
Needham
Hold
Reiterates
n/a
HoldReiteratesn/an/aJun 17, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
613.13M
from 441.54M
Increased by 38.86%
Revenue Next Year
740.62M
from 613.13M
Increased by 20.79%
EPS This Year
2.41
from 1.01
Increased by 138.21%
EPS Next Year
2.79
from 2.41
Increased by 15.93%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
25.64M30.26M93.46M241.62M441.54M613.13M740.62M
Revenue Growth
8.62%18.03%208.83%158.53%82.74%38.86%20.79%
EPS
-1.16-1.60-1.23-0.771.012.412.79
EPS Growth
-----138.21%15.93%
Forward PE
-----47.8741.30
No. Analysts
-----1212
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High635.3M797.2M
Avg613.1M740.6M
Low585.2M673.7M

Revenue Growth

Revenue Growth20252026202720282029
High
43.9%
30.0%
Avg
38.9%
20.8%
Low
32.5%
9.9%

EPS Forecast

EPS202520262027
High2.713.41
Avg2.412.79
Low2.052.16

EPS Growth

EPS Growth202520262027
High
168.2%
41.8%
Avg
138.2%
15.9%
Low
102.8%
-10.4%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.